HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

BioAegis and Prenosis partner for inflammatory disease therapies

BioAegis Therapeutics has entered a strategic partnership with Prenosis to advance AI-driven precision medicine for inflammatory diseases.

By Pharmaceutical Technology · Apr 22, 2026 · via Pharmaceutical Technology
BioAegis and Prenosis partner for inflammatory disease therapies

Image: Pharmaceutical Technology

Tags
theweekformat:headlineheadlinePharmaceutical Technology
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
Opinion: The podcast bringing together MAHA and public health for hard conversations
The WeekSTAT News ↗
Opinion: The podcast bringing together MAHA and public health for hard conversations
“These sides aren't talking to each other. And there's a lot riding on it”: The hosts of “Why Should I Trust Y…
Apr 18, 2026
KFF Unveils “The Business of Health” Podcast with Chip Kahn
The WeekBriefing
KFF Unveils “The Business of Health” Podcast with Chip Kahn
KFF’s new weekly podcast debuts April 2026, diving into healthcare’s financial and policy mechanics, starting …
Apr 17, 2026
Vertical Integration Bends MLR Rules as Copay Maximizers Expand
The WeekBriefing
Vertical Integration Bends MLR Rules as Copay Maximizers Expand
Drug Channels’ April roundup highlights how vertical integration and copay maximizers are changing the economi…
Apr 17, 2026